Achieving Pharma 4.0 Through Physical Science-based Digital Twins in R&D and Operations

20 Jun 2023
5.30-6.30pm SGT | Online
Led by:
Sean Bermingham, Head of Industry Strategy, Software for the Process Industries, Siemens, Netherlands
Sean is Head of Industry Strategy at Siemens for Process Industries Software. As head of this division, he has overall responsibility for development of new use cases and software product content for the energy, chemicals, pharmaceuticals, food and beverage and mining industries.
Sean is a leading figure in the development and adoption of mechanistic model-based tools for increasing R&D efficiency and managing risk in areas ranging from clinical trials to tech transfer and operations. He is the driver behind QbD 2.0, which focuses on improving the efficiency of QbD by reintroducing the “sound science” element of the original QbD definition.
He is one of the founders of and the lead for the Systems-based Pharmaceutics Alliance (2013-present) with Bayer, GSK, Lilly, Pfizer, Roche and Sanofi. Sean was also the lead for the £20.4m ADDoPT “Digital Design” Project (2015-2019) with partners including AZ, BMS, GSK & Pfizer.
Sean is a Chemical Engineer with an MSc and a PhD from Delft University of Technology and an Executive MBA from Imperial College London. He joined Siemens PSE in 2000 and was PSE’s Global Head of Consulting for 8 years before forming the Formulated Products business in 2010. In 2023 he moved to his current role.